Diabetes in patients with COVID-19 is associated with a two-fold increase in mortality as well as severity of COVID-19

Objectives:
Many studies on COVID-19 have reported diabetes to be associated with severe disease and mortality, however, the data is conflicting. Therefore, this review article has been conducted.

Does diabetes increase risk of COVID-19 infection?

Study design:
This review article included 33 case-control studies with 16,003 patients (8,849 (55%) were reported from Mainland China, 7,030 (44%) from USA and 124 (1%) from France). The pooled mean age was 52.6 ± 17.4 years.

Fever is the most common symptom in patients with COVID-19

Objectives:
What are the risk factors of COVID-19?

Study design:
This review article included 21 clinical studies with a total of 47,344 patients (24,419 male and 22,925 females).
The number of cases in the selected studies varied by approximately 3722-fold and ranged from 12 to 44,672 cases.
The sex ratio (male to female) was 1.06 and the overall average age of the subjects was greater than 40 years.

Higher serum levels of homocysteine increase multiple sclerosis

Objectives:
Multiple sclerosis (MS) is a demyelinating and disabling inflammatory disease of the central nervous system. Multiple sclerosis is triggered by complex environmental factors which mostly affect genetically the susceptible young people. Emerging data has suggested that changes of homocysteine (Hcy), vitamin B12 and folate serum levels may be associated with multiple sclerosis. However, previous findings are not always consistent. Therefore, this review aricle has been conducted.

COVID-19 patients have elevated C-reactive protein, decreased lymphocyte count and increased lactate dehydrogenase

Objectives:
What are the risk factors and laboratory abnormalities of COVID-19?

Study design:
This review article included 43 studies involving 3,600 patients.

Results and conclusions:   
The investigators found among COVID-19 patients, fever [83.3%, 95% CI = 78.4 to 87.7], cough [60.3%, 95% CI = 54.2 to 66.3] and fatigue [38.0%, 95% CI = 29.8 to 46.5] were the most common clinical symptoms.

ELISA tests have a specificity higher than 99% and sensitivity of 93% for COVID-19 infection

Objectives:
The emergence of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 made imperative the need for diagnostic tests that can identify the infection. Although Nucleic Acid Test (NAT) is considered to be the gold standard, serological tests based on antibodies could be very helpful. However, individual studies are usually inconclusive. Therefore, this review article has been conducted.

What is the specificity and sensitivity of all available antibody-tests for SARS-CoV-2 (COVID-19) infection?

Seroprotection rate and seroconversion rate of older adults are lower than those in younger adults influenza virus infection

Objectives:
Older people (≥60 years old) are particularly vulnerable to influenza virus infection and vaccine is effective in reducing the disease burden in this population. However, it remains obscure whether their antibody response is lower than those of younger adults (18-60 years old). Therefore, this review article has been conducted.

An increased risk of severity and mortality in COVID-19 patients with liver disease or chronic kidney disease

Objectives:
Does liver disease or chronic kidney disease increase risk of severity and mortality in COVID-19 patients?

Study design:
This review article included 22 studies with a total of 5,595 COVID-19 patients, of which 2,045 (36.55%) were female.
Where reported, 147/5,305 (2.77%) and 83/5,038 (1.65%) had comorbidities of liver diseases and chronic kidney disease, respectively.
The mean ±SD (range) of the sample sizes of all included studies was 254.32 ± 385.76 (29-1,591).